SYROS PHARMACEUTICALS, INC. Operating Lease, Liability, Current
SYROS PHARMACEUTICALS, INC. had Operating Lease, Liability, Current of $2.58 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2024-10-31
- 2024-09-30: Operating Lease, Liability, Current $2.58M.
- 2024-06-30: Operating Lease, Liability, Current $2.50M.
- 2024-03-31: Operating Lease, Liability, Current $2.41M.
- 2023-12-31: Operating Lease, Liability, Current $2.32M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-09-30 | $2.58M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $2.50M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $2.41M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.32M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $2.24M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.16M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.08M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.01M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.93M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.86M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.79M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.72M 10-K · filed 2023-03-02 |
| 2021-09-30 | $1.65M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $1.59M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.52M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.34M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.29M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.04M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.98M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.63M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-01 |